Moderna Management

Management criteria checks 2/4

Moderna's CEO is Stephane Bancel, appointed in Oct 2011, has a tenure of 12.33 years. total yearly compensation is $19.36M, comprised of 7.3% salary and 92.7% bonuses, including company stock and options. directly owns 5.52% of the company’s shares, worth $1.98B. The average tenure of the management team and the board of directors is 4.1 years and 9.8 years respectively.

Key information

Stephane Bancel

Chief executive officer

US$19.4m

Total compensation

CEO salary percentage7.3%
CEO tenure12.3yrs
CEO ownership5.5%
Management average tenure4.1yrs
Board average tenure9.8yrs

Recent management updates

Recent updates

Moderna: Counting On Pipeline Too Much

Feb 23

Moderna: Highly Uncertain Future For mRNA Vaccine In A Post-Pandemic World

Feb 16

Moderna: Fade 2025 Outlook

Jan 15

Moderna, Inc. (NASDAQ:MRNA) Held Back By Insufficient Growth Even After Shares Climb 26%

Dec 29
Moderna, Inc. (NASDAQ:MRNA) Held Back By Insufficient Growth Even After Shares Climb 26%

Need To Know: The Consensus Just Cut Its Moderna, Inc. (NASDAQ:MRNA) Estimates For 2024

Nov 03
Need To Know: The Consensus Just Cut Its Moderna, Inc. (NASDAQ:MRNA) Estimates For 2024

Moderna, Inc. (NASDAQ:MRNA) Shares Could Be 30% Below Their Intrinsic Value Estimate

Oct 18
Moderna, Inc. (NASDAQ:MRNA) Shares Could Be 30% Below Their Intrinsic Value Estimate

Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 47% Discount?

May 23
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 47% Discount?

Weak Statutory Earnings May Not Tell The Whole Story For Moderna (NASDAQ:MRNA)

Mar 03
Weak Statutory Earnings May Not Tell The Whole Story For Moderna (NASDAQ:MRNA)

Earnings Working Against Moderna, Inc.'s (NASDAQ:MRNA) Share Price Following 28% Dive

Feb 25
Earnings Working Against Moderna, Inc.'s (NASDAQ:MRNA) Share Price Following 28% Dive

Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 48% Discount?

Feb 08
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 48% Discount?

CEO Compensation Analysis

How has Stephane Bancel's remuneration changed compared to Moderna's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$5b

Sep 30 2023n/an/a

-US$3b

Jun 30 2023n/an/a

US$1b

Mar 31 2023n/an/a

US$5b

Dec 31 2022US$19mUS$1m

US$8b

Sep 30 2022n/an/a

US$12b

Jun 30 2022n/an/a

US$14b

Mar 31 2022n/an/a

US$15b

Dec 31 2021US$18mUS$990k

US$12b

Sep 30 2021n/an/a

US$7b

Jun 30 2021n/an/a

US$3b

Mar 31 2021n/an/a

US$598m

Dec 31 2020US$13mUS$946k

-US$747m

Sep 30 2020n/an/a

-US$597m

Jun 30 2020n/an/a

-US$488m

Mar 31 2020n/an/a

-US$505m

Dec 31 2019US$9mUS$921k

-US$514m

Sep 30 2019n/an/a

-US$535m

Jun 30 2019n/an/a

-US$499m

Mar 31 2019n/an/a

-US$459m

Dec 31 2018US$59mUS$863k

-US$402m

Sep 30 2018n/an/a

-US$299m

Jun 30 2018n/an/a

-US$280m

Mar 31 2018n/an/a

-US$266m

Dec 31 2017US$7mUS$651k

-US$270m

Compensation vs Market: Stephane's total compensation ($USD19.36M) is above average for companies of similar size in the US market ($USD12.07M).

Compensation vs Earnings: Stephane's compensation has increased whilst the company is unprofitable.


CEO

Stephane Bancel (50 yo)

12.3yrs

Tenure

US$19,363,648

Compensation

Mr. Stephane Bancel serves as Board Director of Indigo Agriculture Inc since 2020. Mr Bancel serves as Interim President of Valera LLC. Mr. Bancel serves as a Special Partner at Flagship Pioneering since F...


Leadership Team

NamePositionTenureCompensationOwnership
Stephane Bancel
CEO & Director12.3yrsUS$19.36m5.52%
$ 2.0b
Stephen Hoge
Presidentno dataUS$8.65m0.44%
$ 157.0m
James Mock
Chief Financial Officer1.4yrsUS$7.33m0.00095%
$ 341.3k
Jerh Collins
Chief Technical Operations & Quality Officer1.1yrsno datano data
Melissa Moore
Chief Scientific Officer & Member of Scientific Advisory Board7.3yrsno datano data
Brad Miller
Chief Information Officer1.1yrsno datano data
Lavina Talukdar
Senior VP & Head of Investor Relations4.8yrsno datano data
Shannon Klinger
Chief Legal Officer & Corporate Secretary2.7yrsUS$11.76m0.0021%
$ 743.6k
Colleen Hussey
Senior Director of Corporate Communicationsno datano datano data
Tracey Franklin
Chief Human Resources Officer4.3yrsno datano data
Melanie Ivarsson
Chief Development Officer4.1yrsno datano data
Dave Johnson
Chief Data & AI Officerno datano datano data

4.1yrs

Average Tenure

50yo

Average Age

Experienced Management: MRNA's management team is considered experienced (4.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Stephane Bancel
CEO & Director12.9yrsUS$19.36m5.52%
$ 2.0b
Melissa Moore
Chief Scientific Officer & Member of Scientific Advisory Boardno datano datano data
Noubar Afeyan
Co-Founder14.1yrsUS$534.14k0.56%
$ 201.9m
Elizabeth Tallett
Independent Director3.6yrsUS$478.55k0.00018%
$ 64.7k
Robert Langer
Independent Non Executive Director & Member of Scientific Advisory Board13.2yrsUS$452.92k3.01%
$ 1.1b
Scott Canute
Member of Technology Advisory Board9.8yrsno datano data
Elizabeth Nabel
Independent Director2.9yrsUS$460.32k0.00036%
$ 129.3k
Fred Regnier
Member of Technology Advisory Board9.8yrsno datano data
Francois Nader
Independent Non Executive Director4.2yrsUS$467.30k0.0054%
$ 1.9m
Ulrich von Andrian-Werburg
Member of Scientific Advisory Boardno datano datano data
Jack Szostak
Chairman of Scientific Advisory Board9.8yrsno datano data
John Aunins
Member of Technology Advisory Board9.8yrsno datano data

9.8yrs

Average Tenure

64yo

Average Age

Experienced Board: MRNA's board of directors are considered experienced (9.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.